Canada markets close in 2 hours 1 minute

Shanghai Junshi Biosciences Co., Ltd. (SHJBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.86000.0000 (0.00%)
As of 09:51AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.55B
Enterprise Value 3.32B
Trailing P/E N/A
Forward P/E 666.67
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.13
Price/Book (mrq)1.93
Enterprise Value/Revenue 2.04
Enterprise Value/EBITDA -1.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3-49.04%
S&P500 52-Week Change 322.43%
52 Week High 33.6500
52 Week Low 30.9524
50-Day Moving Average 31.9320
200-Day Moving Average 32.5160

Share Statistics

Avg Vol (3 month) 34
Avg Vol (10 day) 3N/A
Shares Outstanding 5219.3M
Implied Shares Outstanding 61.91B
Float 8671.18M
% Held by Insiders 122.43%
% Held by Institutions 122.84%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -124.25%
Operating Margin (ttm)-84.41%

Management Effectiveness

Return on Assets (ttm)-11.32%
Return on Equity (ttm)-26.95%

Income Statement

Revenue (ttm)1.63B
Revenue Per Share (ttm)1.66
Quarterly Revenue Growth (yoy)49.20%
Gross Profit (ttm)N/A
EBITDA -1.92B
Net Income Avi to Common (ttm)-2.02B
Diluted EPS (ttm)-0.2800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.56B
Total Cash Per Share (mrq)4.67
Total Debt (mrq)3.03B
Total Debt/Equity (mrq)43.16%
Current Ratio (mrq)2.09
Book Value Per Share (mrq)7.03

Cash Flow Statement

Operating Cash Flow (ttm)-1.66B
Levered Free Cash Flow (ttm)-1.9B